We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+16.95%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$1.52B
AUM Growth
-$7.28B
Cap. Flow
-$6.76B
Cap. Flow %
-444.29%
Top 10 Hldgs %
100%
Holding
929
New
–
Increased
6
Reduced
3
Closed
920

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
FHN icon
First Horizon
FHN
+$107M
3
SGFY
Signify Health, Inc.
SGFY
+$54.9M
4
VMW
VMware, Inc
VMW
+$34.9M
5
ONEM
1Life Healthcare
ONEM
+$29.7M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
ROG icon
Rogers Corp
ROG
+$432M
4
AVLR
Avalara, Inc.
AVLR
+$373M
5
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M

Sector Composition

Rank Sector Weight
1 Technology 45.54%
2 Healthcare 36.97%
3 Financials 14.43%
4 Communication Services 3.06%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATVI
1
DELISTED
Activision Blizzard
ATVI
$423M 27.77%
5,522,582
-610,211
-10% -$45.3M
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$260M 17.09%
2,285,790
+2,211,443
+2,974% +$184M
FHN icon
3
First Horizon
FHN
$12.1B
$220M 14.43%
8,964,849
+4,396,038
+96% +$107M
SGFY
4
DELISTED
Signify Health, Inc.
SGFY
$161M 10.59%
5,627,568
+1,903,721
+51% +$54.9M
ONEM
5
DELISTED
1Life Healthcare
ONEM
$141M 9.29%
8,459,920
+1,760,716
+26% +$29.7M
VMW
6
DELISTED
VMware, Inc
VMW
$121M 7.97%
988,899
+302,953
+44% +$34.9M
SIMO icon
7
Silicon Motion
SIMO
$9.07B
$75.2M 4.94%
1,157,028
+6,486
+0.6% +$398K
TSEM icon
8
Tower Semiconductor
TSEM
$25.4B
$74M 4.86%
1,713,535
-46,092
-3% -$2M
TGNA
9
DELISTED
TEGNA Inc
TGNA
$46.6M 3.06%
2,200,000
-1,758,983
-44% -$35.5M
AAL icon
10
PUT
American Airlines Group
AAL
$10.6B
– –
-16,369,200
Closed -$21.2M
AAPL icon
11
PUT
Apple
AAPL
$4.56T
– –
-100,000
Closed -$1.28M
ABBV icon
12
AbbVie
ABBV
$431B
– –
-10,402
Closed -$1.4M
ABR icon
13
Arbor Realty Trust
ABR
$957M
– –
-696,844
Closed -$8.01M
ACEL icon
14
Accel Entertainment
ACEL
$998M
– –
-382,031
Closed -$2.98M
ACM icon
15
Aecom
ACM
$9.63B
– –
-104,535
Closed -$7.15M
ACRS icon
16
Aclaris Therapeutics
ACRS
$851M
– –
-113,426
Closed -$1.78M
ADC icon
17
Agree Realty
ADC
$9.5B
– –
-188,873
Closed -$12.8M
ADPT icon
18
Adaptive Biotechnologies
ADPT
$3.75B
– –
-143,490
Closed -$1.02M
ADT icon
19
ADT
ADT
$5.59B
– –
-79,596
Closed -$596K
ADT icon
20
PUT
ADT
ADT
$5.59B
– –
-90,300
Closed -$182K
AEE icon
21
Ameren
AEE
$30B
– –
-36,245
Closed -$2.92M
AENTW icon
22
Alliance Entertainment Holding Corp Warrants
AENTW
$4.27M
– –
-120,589
Closed -$22K
AEON icon
23
AEON Biopharma
AEON
$13.8M
– –
-6,601
Closed -$4.68M
AES icon
24
AES
AES
$10.5B
– –
-191,048
Closed -$4.32M
AFRM icon
25
PUT
Affirm
AFRM
$25.6B
– –
-60,000
Closed -$309K
1
2 3 4 5

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 929 positions worth $1.52B, down 83% from $8.8B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

UBS O'Connor withdrew a net $6.76B in Q4 2022, closing 920 positions and reducing 3 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS O'Connor added an estimated $184M to Horizon Therapeutics Public Limited Company Ordinary Shares.

  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $45.3M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 100% of its $1.52B portfolio in Q4 2022.
  • UBS O'Connor opened 0 new positions and closed 920 in Q4 2022.
  • UBS O'Connor's portfolio value fell 83% quarter-over-quarter to $1.52B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.